跳至主要内容
临床试验/NL-OMON33571
NL-OMON33571已完成2 期

Organ protection by noble gases - helium therapy in acute ischemic stroke - Helium in ischemic stroke

Gooi-Noord Ziekenhuis0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • age >= 18 years;
  • clinical anterior circulation ischemic stroke;
  • < 12 hours of witnessed symptom onset
  • National Institutes of Health Stroke Scale (NIHSS) score >= 4;
  • pre-admission modified Rankin scale (mRS, dutch version) <= 1;
  • Visual estimation of penumbra/infarct ratio > 20%

排除标准

  • eligible for rt-PA thrombolysis;
  • inability to obtain written informed consent;
  • legal incapacity
  • medically instable (blood pressure >230/120 or <100/60 mmHg, pulse > 120 bpm, mechanical ventilation needed, body temperature above 39*C)
  • intracerebral hemorrhage on admission non-enhanced CT;
  • rapidly improving neurological deficits;
  • impaired renal function (serum creatinin levels > 130 µmol/l)
  • allergic to contrast agent;
  • use of anticoagulation drugs or coagulopathy (PTT > 1.5 times control)
  • use following nephrotoxic medications: aminoglycosids, amfoterecine B or cisplatin
  • contra-indication or intolerance to any used substance;

研究者

发起方
Gooi-Noord Ziekenhuis

相似试验